Consolidated Statement of Operations - USD ($) shares in Thousands, $ in Thousands	8 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Operating expenses
Selling and administrative expenses	$ 4,526	$ 28,787
Research and development expenses	5,865	73,694
Total operating expenses	10,391	102,481
Loss from operations	(10,391)	(102,481)
Other (expense) income
Other expense		(20,866)
Interest expense		(703)
Loss before income taxes	(10,391)	(124,050)
Income tax expense		0
Net loss	$ (10,391)	$ (124,050)
Loss per share attributable to common shareholders
Basic & Diluted (in dollars per share)	$ (0.15)	$ (1.28)
Weighted-average number of common shares outstanding
Basic & Diluted (in shares)	68,279	96,716